4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-105517
Chief Scientific Officer sold 2,161 shares at $31.89 ($68,914)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2024-09-11 | Sale 10b5-1 | −2,161 | $31.89 | $68,914 | 142,714 | D |
| Open-market sales · 2,161 sh · avg $31.89 · $68,914 | |||||||
Loading xslF345X05/ownership.xml…